Our previous study has elucidated the role of HERC2 in fostering inflammation‐driven cellular plasticity and immune evasion in HCC.[12a] The current research newly demonstrated that elevated levels of HERC2 in hepatic tissue are essential in conferring protection against DILI. The gene discussed is HERC2; the disease is hepatocellular carcinoma.